Provided are pharmaceutical compositions and methods of treating or preventing edema, using an anti-T cell agent, an anti- TGF-β1 agent, or an anti -angiotensin agent, preferably a combination of at least two such agents. The pharmaceutical compositions can be formulated for systemic or local administration, and are preferably administered topically.